Longley D - Search Results

1

Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy.

Van Schaeybroeck S, Karaiskou-McCaul A, Kelly D, Longley D, Galligan L, Van Cutsem E, Johnston P. Van Schaeybroeck S, et al. Among authors: longley d. Clin Cancer Res. 2005 Oct 15;11(20):7480-9. doi: 10.1158/1078-0432.CCR-05-0328. Clin Cancer Res. 2005. PMID: 16243822

2

Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.

Longley DB, Ferguson PR, Boyer J, Latif T, Lynch M, Maxwell P, Harkin DP, Johnston PG. Longley DB, et al. Clin Cancer Res. 2001 Nov;7(11):3533-9. Clin Cancer Res. 2001. PMID: 11705873

3

Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma.

Wong NA, Brett L, Stewart M, Leitch A, Longley DB, Dunlop MG, Johnston PG, Lessells AM, Jodrell DI. Wong NA, et al. Among authors: longley db. Br J Cancer. 2001 Dec 14;85(12):1937-43. doi: 10.1054/bjoc.2001.2175. Br J Cancer. 2001. PMID: 11747337 Free PMC article.

4

The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG. Longley DB, et al. Cancer Res. 2002 May 1;62(9):2644-9. Cancer Res. 2002. PMID: 11980662

5

Clinical significance of prognostic and predictive markers in colorectal cancer.

Longley DB, McDermott U, Johnston PG. Longley DB, et al. Pharmacogenomics J. 2002;2(4):209-16. doi: 10.1038/sj.tpj.6500124. Pharmacogenomics J. 2002. PMID: 12196910 Review. No abstract available.

6

Molecular and biochemical markers in colorectal cancer.

McDermott U, Longley DB, Johnston PG. McDermott U, et al. Among authors: longley db. Ann Oncol. 2002;13 Suppl 4:235-45. doi: 10.1093/annonc/mdf665. Ann Oncol. 2002. PMID: 12401696 Free article. Review. No abstract available.

7

Predictive markers for colorectal cancer: current status and future prospects.

Longley DB, McDermott U, Johnston PG. Longley DB, et al. Clin Colorectal Cancer. 2003 Feb;2(4):223-30. doi: 10.3816/CCC.2003.n.003. Clin Colorectal Cancer. 2003. PMID: 12620141 Review.

8

5-fluorouracil: mechanisms of action and clinical strategies.

Longley DB, Harkin DP, Johnston PG. Longley DB, et al. Nat Rev Cancer. 2003 May;3(5):330-8. doi: 10.1038/nrc1074. Nat Rev Cancer. 2003. PMID: 12724731 Review.

9

The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells.

Longley DB, Latif T, Boyer J, Allen WL, Maxwell PJ, Johnston PG. Longley DB, et al. Semin Oncol. 2003 Jun;30(3 Suppl 6):3-9. doi: 10.1016/s0093-7754(03)00119-2. Semin Oncol. 2003. PMID: 12802789

10

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG. Maxwell PJ, et al. Among authors: longley db. Cancer Res. 2003 Aug 1;63(15):4602-6. Cancer Res. 2003. PMID: 12907638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters